Warmer weather, looser restrictions draw students to gather outdoors
Loosening restrictions and the warmer weather are beginning to draw students outside where experts say gathering is safer — but still not risk free.
When elected officials control the maps, they are not just participating in democracy. They are engineering the habitat in which democracy thrives or languishes. That makes redistricting not only a political problem, but also an operations research problem.
INFORMS has awarded Microsoft (NASDAQ: MSFT) its 2026 Franz Edelman Award for Achievement in Advanced Analytics, Operations Research and Management Science, for reengineering how global cloud infrastructure is planned and delivered, applying advanced analytics and AI to orchestrate complex fulfillment decisions across its rapidly expanding data center network.
In the rush to adopt artificial intelligence, many employers are now requiring that employees use AI tools. As you’re using AI, be intentional and selective. It’s critical that you know yourself. Research published in Management Science found that AI is most valuable for people who understand their own abilities and limitations. Assess yourself, so you can factor this into your process for incorporating AI into your work.
An audio journey of how data and analytics save lives, save money and solve problems.

Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
Loosening restrictions and the warmer weather are beginning to draw students outside where experts say gathering is safer — but still not risk free.
Tens of millions of people across the U.S. have received a coronavirus vaccine. So far, the majority of doses have been either the Moderna or Pfizer vaccine, both of which use mRNA to generate an immune response. These gene-based vaccines have been in the works for decades, but this is the first time they have been used widely in people.
The various Covid-19 vaccines currently being distributed around the globe have the potential to end the worst pandemic in a century. They also will mean hundreds of billions dollars in sales for the pharmaceutical companies that make them.
Good evening. I’m Deborah Netburn, a science and features writer at the Los Angeles Times, filling in for Thuc Nhi Nguyen for a few days. You may remember me from my previous stints with the newsletter — it’s nice to be back! It’s Monday, March 15, and here’s what’s happening with the coronavirus in California and beyond.
Developing the vaccines was a gamble for the all the companies that tried, even with most drug makers accepting government grands.

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine